Integrated Core Strategies (US) LLC 13D and 13G filings for Myriad Genetics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-05-01 4:21 pm Purchase | 2024-04-25 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (US) LLC | 4,544,150 5.000% | 50,889 (+1.13%) | Filing |
| 2024-04-25 4:18 pm Purchase | 2024-04-17 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (US) LLC | 4,493,261 4.970% | 931,924 (+26.17%) | Filing |
| 2024-01-23 4:31 pm Sale | 2023-12-31 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (US) LLC | 3,561,337 4.000% | -699,704 (-16.42%) | Filing |
| 2023-10-17 4:14 pm Purchase | 2023-10-10 | 13G | Myriad Genetics, Inc. MYGN | Integrated Core Strategies (US) LLC | 4,261,041 5.200% | 4,261,041 (New Position) | Filing |